Holen Sie sich die Stockscreener-App
7.98
0.22%
-0.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Finanzdaten der Neogenomics Inc-Aktie (NEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.26%
190.17
|
187.80 | 181.33 | 168.03 | 172.00 |
| Cost Of Revenue |
0.49%
106.83
|
107.35 | 104.07 | 94.79 | 94.74 |
| Gross Profit |
3.60%
83.34
|
80.45 | 77.26 | 73.25 | 77.26 |
Operating Expenses
|
9.96%
96.76
|
107.46 | 124.89 | 101.07 | 95.66 |
| Benefits Costs and Expenses |
5.42%
202.58
|
214.19 | 227.15 | 193.69 | 188.13 |
| Costs And Expenses |
5.42%
202.58
|
214.19 | 227.15 | 193.69 | 188.13 |
| Operating Income/Loss |
50.34%
-13.41
|
-27.01 | -47.63 | -27.82 | -18.40 |
| Income/Loss From Continuing Operations Before Tax |
52.99%
-12.41
|
-26.39 | -45.82 | -25.66 | -16.13 |
| Income Tax Expense/Benefit |
441.22%
-2.525
|
0.74 | -0.724 | 0.266 | -0.804 |
| Income/Loss From Continuing Operations After Tax |
63.58%
-9.881
|
-27.13 | -45.09 | -25.92 | -15.32 |
|
Net Income/Loss
|
63.58%
-9.881
|
-27.13 | -45.09 | -25.92 | -15.32 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.86%
0.184
|
128.41 | 127.95 | 127.38 | 0.167 |
| Diluted Average Shares |
99.86%
0.184
|
128.41 | 127.95 | 127.38 | 0.167 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.05%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):